Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

13 Jan 2010 10:04

RNS Number : 4720F
Seymour Pierce Ltd
13 January 2010
 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Seymour Pierce Limited

Company dealt in

Fulcrum Pharma plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary 1p Shares

Date of dealing

12.01.10

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

3,000

0.0250GBP

0.0250GBP

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

13.01.10

Contact name

Caroline Woodyer

Telephone number

020 7107 8056

Name of offeree/offeror with which connected

Fulcrum Pharma plc

Nature of connection (Note 6)

Nomad and Broker

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMKKNDKKBKDQDD
Date   Source Headline
4th Oct 20215:47 pmRNSExercise of Options and Total Voting Rights
4th Oct 20211:10 pmRNSExercise of Options and Total Voting Rights
30th Sep 20212:45 pmRNSTotal Voting Rights
29th Sep 20215:55 pmRNSResult of AGM
29th Sep 20217:00 amRNSAGM Statement
24th Sep 20214:05 pmRNSResults of Placing
24th Sep 20213:00 pmRNSExercise of Options and Proposed Secondary Placing
16th Sep 20215:57 pmRNSExercise of Options and Total Voting Rights
14th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
10th Sep 20215:24 pmRNSExercise of Options and Total Voting Rights
7th Sep 20217:00 amRNSNotice of Annual General Meeting
2nd Sep 20212:41 pmRNSExercise of Options and Total Voting Rights
1st Sep 20215:01 pmRNSTotal Voting Rights
27th Aug 20219:50 amRNSDirector/PDMR Shareholding
26th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
17th Aug 20217:00 amRNSFinal Results
5th Aug 20217:00 amRNSChange of Nomad and Broker
28th May 20217:00 amRNSTrading Update
30th Apr 20215:00 pmRNSTotal Voting Rights
23rd Apr 20213:30 pmRNSGrant & exercise of options and TVR
23rd Apr 20217:00 amRNSTrading Update
7th Apr 20215:09 pmRNSHolding(s) in Company
31st Mar 20215:00 pmRNSTotal Voting Rights
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSHolding(s) in Company
24th Feb 20213:55 pmRNSExercise of options and Director dealings
22nd Feb 20217:00 amRNSExercise of options and Director dealings
9th Feb 20214:35 pmRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSHalf-year Report
25th Nov 20209:53 amRNSResult of Annual General Meeting
25th Nov 20207:00 amRNSAGM statement and Trading Update
2nd Nov 20202:01 pmRNSPosting of Annual Report & Notice of AGM
15th Oct 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSTrading update and extension of results deadline
28th Aug 20205:15 pmRNSTotal Voting Rights
20th Aug 20202:05 pmRNSSecond Price Monitoring Extn
20th Aug 20202:00 pmRNSPrice Monitoring Extension
20th Aug 20201:18 pmRNSHolding(s) in Company
20th Aug 20208:01 amRNSCompletion of banking facilities & trading update
10th Aug 202011:05 amRNSSecond Price Monitoring Extn
10th Aug 202011:00 amRNSPrice Monitoring Extension
6th Aug 20208:41 amRNSResult of fundraise & Director shareholdings
6th Aug 20207:00 amRNSTrading update and proposed fundraise
30th Apr 20204:35 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSTrading update
17th Mar 202011:06 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.